Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$11.94 USD
+0.12 (1.02%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $11.98 +0.04 (0.34%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth F Momentum D VGM
Walgreens Boots Alliance (WBA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.60 | $22.00 | $7.00 | 15.06% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Walgreens Boots Alliance comes to $13.60. The forecasts range from a low of $7.00 to a high of $22.00. The average price target represents an increase of 15.06% from the last closing price of $11.82.
Analyst Price Targets (15)
Broker Rating
Walgreens Boots Alliance currently has an average brokerage recommendation (ABR) of 3.08 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 3.08 a month ago based on 16 recommendations.
Of the 16 recommendations deriving the current ABR, two are Strong Buy, representing 12.5% of all recommendations. A month ago, Strong Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 10 | 10 | 10 | 10 | 10 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/27/2024 | SVB Securities | Michael Cherny | Hold | Hold |
6/24/2024 | UBS | Kevin Caliendo | Hold | Hold |
6/18/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
6/17/2024 | Not Identified | Not Identified | Hold | Hold |
6/6/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
6/3/2024 | Evercore Partners | Elizabeth Anderson | Hold | Hold |
4/1/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
4/1/2024 | Truist Securities | David S Macdonald | Hold | Hold |
3/26/2024 | Raymond James | John W Ransom | Hold | Hold |
2/21/2024 | Not Identified | Not Identified | Hold | Hold |
2/20/2024 | Not Identified | Not Identified | Hold | Moderate Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.08 |
ABR (Last week) | 3.08 |
# of Recs in ABR | 16 |
Average Target Price | $13.60 |
LT Growth Rate | 5.00% |
Industry | Retail - Pharmacies and Drug Stores |
Industry Rank by ABR | 242 of 252 |
Current Quarter EPS Est: | 0.36 |